Results 141 to 150 of about 58,007 (253)
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial)
Alimentary Pharmacology &Therapeutics, Volume 61, Issue 11, Page 1740-1754, June 2025.There is no evidence of a difference between carvedilol 12.5 mg daily and VBL in the primary prevention of variceal bleeding in patients with cirrhosis and medium‐to large‐sized oesophageal varices. Carvedilol has no untoward safety concerns, is well tolerated, cost‐saving and potentially cost‐effective and is the preferred first‐line primary ...Dhiraj Tripathi, Kelly Handley, Lisa Holden, Zainab Abdali, Sue Jowett, Jonathan Mathers, Christopher Poyner, Paul Richardson, James Ferguson, Ian Rowe, CALIBRE trial collaborative group, Ashis Mukhopadhya, Jennifer Cathcart, Pauline Dundas, Oluyemi Solanke, Siby Joseph, Cyril Sieberhagen, Melanie Harrison, Claire Burston, Gavin Wright, Princess Gabiana, Aimee Williams, Bushena Miyesa, John Ramage, Hayley Cousins, Rachel Bryant, Sim L. Lim, Janisha Patel, Mel Penacerrada, Rachel Lorusso, Rory McCorry, Allison Lloyd, Heather Lawther, Safa Al‐Shamma, Anna Maria Wilce, Sulleman Moreea, Carol Firth, Robert Przemioslo, Charlotte Cranfield, Joanna Leithead, Gwilym Webb, Victoria Snowdon, Aarani Mahalingam, Abigail Ford, Thomas Pembroke, Sarah Harrhy, Fiona Greaves, Matthew Foxton, Carina Bautista, Esther Unitt, Susan Dale, Andrew Austin, Catherine Addleton, Sharan Shetty, Rizwan Mahmood, Clare Allcock, Karen Reid, Michael Miller, Anne Elliott, Leanne Cosgrove, Shona Murray, Francisco Porra Pérez, Melanie Kent, Marie Callaghan, Dina Mansour, Ann Wilson, Adrian Stanley, Alexis Duncan, Lauren Walker, Coral Hollywood, Paula Hiltout, Phil Berry, Jessica Cordle, Andrew King, Laurence Hopkins, Faye Moore, Mirriam Sangombe, Lynsey Corless, Tania Nurun, Julie Wilcox, Bethia Featherstone, Ameet Dhar, Maria Lanoria, Gary Hahn, Brian Hogan, Mark McPhail, Matthew M. Farrant, Nicola Griffiths, Ane Zamalloa, Victoria Appleby, Mark Aldersley, Rebecca Bishop, Louise Clark, Farooq Khan, Ka‐Kit Li, Olivia Watchorn, John Hutchinson, Patricia Kane, Julie Burton, Stephanie Lupton, Jacqui Bartholomew, Emma‐Jane Stoner, Steven Masson, Sarah Hogg, Simon Rushbrook, Vanessa Martin, Tom Lee, Jane Luke, Angela Green, Stephen Ryder, Preethi Shibu, Jeremy Cobbold, Loren Smith, Lou Holland, Eleni Rountenko, Matthew Cramp, Alex Parkinson, Richard Aspinall, Emily Jones, Jincy Daniels, Anu Andrews, Hyder Hussaini, Lisa Trembath, Fiona Hammonds, Ben Hudson, Rob James, Raj Mookerjee, Christine Eastgate, Gloria Ferrariz, Abigail Brownlie, Dai Samuel, Bethan Deacon, Imran Patanwala, Edward Britton, Callum Wood, Martina Lofthouse, Giovanna Bretland, Vikram Sharma, Louise Payaniandy, James Hand, Graham Branagan, Aqueel Jamil, Alpha Anthony, Louise Bell, Ahmed Abu‐Shanab, Samia Hussain, Manjinder Gohel, Charlie Millson, Kerry Elliott, Tania Neale, Laura Harrison, Barbara Hoeroldt, Ihteshamul Haq, Angela Liaros, Holly Caborn, Ulrich Thalheimer, Kate Winstance, Darren Craig, Julie Tregonning, Janisha Patel, Helen Stone, Lijamol Joseph, Jisha Jacob, Joanne Topping, Peter Murphy, Jill Effard, Sarah Hughes, Criscel Jan Pelaez, Rohit Sinha, Jenny Henderson, Jagdish Nagaraj, Chin Lye Ch’Ng, Caradog Thomas, Elaine Brinkworth, Moby Joseph, Andrew Claridge, James Neale, Camille Walling, Maggie Ryder, Jacinta Ugoji, Neil Rajoriya, Emma Burke, Nishant Gautam, Julie Fletcher, Richard Keld, Philip Paterson, Christopher Corbett, Marie Green, Siobhan Sutton, Naomi Gott, Peter Hayes, Peter Devine, Khaled Ahmed, Kate Brailsford, Peter Brocklehurst, Margaret Grant, Gemma Slinn, Matthew Soden, Rebecca Amos‐Hirst, Hannah Bensoussane, Catherine Moakes, Bhushan Chhajed, Paul Riley, Neil Winkles, Lazaros Andronis, Christel McMullan +205 morewiley +1 more sourceThree‐Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt Dysfunction
Alimentary Pharmacology &Therapeutics, Volume 61, Issue 11, Page 1805-1814, June 2025.Regarding the role of 3D TIPS geometry in predicting TIPS dysfunction, this study identified a larger distance of the cranial stent end from the inferior vena cava and a larger stent curvature as predictors of dysfunction. Therefore, a less curved, more central TIPS is recommended to reduce the risk of dysfunction ABSTRACT Background
Patients with ...Carsten Meyer, Markus Kimmann, Katharina Böhm, Sebastian Nowak, Alba Maria Paar Pérez, Jörn Arne Meier, Sara Noemi Reinartz Groba, Juliana Gödiker, Frank Erhard Uschner, Feras Sanoubara, Johannes Chang, Jonel Trebicka, Alois Martin Sprinkart, Michael Praktiknjo +13 morewiley +1 more sourceInvolvement of the ADAMTS13–von Willebrand factor axis in acute kidney injury in mice with liver cirrhosis
Hepatology Research, Volume 55, Issue 6, Page 844-858, June 2025.Abstract Aim
Hepatorenal syndrome‐induced acute kidney injury (AKI) comprises AKI and liver cirrhosis (LC) and is a risk factor for poor prognoses of patients with LC. Decreased a disintegrin‐like metalloproteinase with thrombospondin type 1 motif 13 (ADAMTS13) activity and increased von Willebrand factor (vWF) antigen levels are associated with LC ...Masayoshi Takami, Norihisa Nishimura, Kosuke Kaji, Nobuyuki Yorioka, Hiroyuki Masuda, Hiroaki Takaya, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji +9 morewiley +1 more sourceInpatient hospital burden of hepatitis C-diagnosed patients with decompensated cirrhosis [PDF]
, 2018 Cheung, Costella, D'Amico, Davis, Deuffic-Burban, el-Serag, European Association for Study of Liver, European Association for the Study of the Liver, Fattovich, Foster, Health Protection Scotland, Innes, Innes, Ioannou, Kendrick, Liu, Martin, McAdam-Marx, McDonald, Petta, R Development Core Team, Santen, Scott, Shaw, Wright, Wright +25 morecore +2 more sourcesChronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation
Journal of Viral Hepatitis, Volume 32, Issue 6, June 2025.ABSTRACT
Nucleos(t)ide analogs (NAs) provide prolonged viral suppression with favourable clinical outcomes in chronic hepatitis B (CHB) patients. Characterisation of adverse hepatic events after NA cessation leading to liver transplantation (LT) is vital to the improvement of patient management and safety considerations.Grishma Hirode, Mai Kilany, Steven Pi, Audrey Kim, Mamatha Bhat, Rafique Van Uum, Leslie B. Lilly, Bettina E. Hansen, Jordan J. Feld, Nazia Selzner, Harry L. A. Janssen +10 morewiley +1 more sourceIdentifying Risk Factors for Hepatocellular Carcinoma in Patients With Delta Hepatitis: A Prognostic Study
Journal of Viral Hepatitis, Volume 32, Issue 6, June 2025.ABSTRACT
Given that delta hepatitis is associated with a 2–6 times higher risk for hepatocellular carcinoma (HCC) compared to HBV monoinfection, we aimed to identify the negative prognostic factors for complications associated with HDV infection (particularly HCC) and to validate BEA score as a screening tool for HCC in HDV.Speranta Iacob, Mirela Chitul, Diana Stan, Daria Gheorghe, Mugur Grasu, Razvan Iacob, Cristian Gheorghe, Irinel Popescu, Liliana Gheorghe +8 morewiley +1 more sourceNon‐Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1‐Negative Myeloproliferative Neoplasms
Liver International, Volume 45, Issue 6, June 2025.ABSTRACT Background & Aims
The course of BCR::ABL1‐negative myeloproliferative neoplasms (MPN) is frequently complicated by thromboembolic events in the splanchnic venous system, resulting in portal hypertension (PH). Therefore, the introduction of spleen stiffness measurement (SSM) might improve the diagnosis of PH.Lorenz Balcar, Lina Degenfeld‐Schonburg, Can Hopp, Georg Kramer, Irene Graf, Lucie Simonis, Christian Sillaber, Stephanie Kalteis, Heinz Gisslinger, Tobias Meischl, Albert Friedrich Stättermayer, Mattias Mandorfer, Gerlinde Mitterbauer‐Hohendanner, Thomas Reiberger, Michael Trauner, Bernhard Scheiner, Maria‐Theresa Krauth, Georg Semmler +17 morewiley +1 more source
